221 related articles for article (PubMed ID: 25241827)
1. Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines.
Ruggieri L; Giannuzzi V; Baiardi P; Bonifazi F; Davies EH; Giaquinto C; Bonifazi D; Felisi M; Chiron C; Pressler R; Rabe H; Whitaker MJ; Neubert A; Jacqz-Aigrain E; Eichler I; Turner MA; Ceci A;
Eur J Pediatr; 2015 Apr; 174(4):481-91. PubMed ID: 25241827
[TBL] [Abstract][Full Text] [Related]
2. The EU paediatric regulation: still a large discrepancy between therapeutic needs and approved paediatric investigation plans.
Wimmer S; Rascher W; McCarthy S; Neubert A
Paediatr Drugs; 2014 Oct; 16(5):397-406. PubMed ID: 25056717
[TBL] [Abstract][Full Text] [Related]
3. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
[TBL] [Abstract][Full Text] [Related]
4. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
Hwang TJ; Tomasi PA; Bourgeois FT
PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
[TBL] [Abstract][Full Text] [Related]
5. The European Regulation on medicines for paediatric use.
Dunne J
Paediatr Respir Rev; 2007 Jun; 8(2):177-83. PubMed ID: 17574163
[TBL] [Abstract][Full Text] [Related]
6. Impact of the EU Paediatric Medicine Regulation on new anti-cancer medicines for the treatment of children and adolescents.
Vassal G; de Rojas T; Pearson ADJ
Lancet Child Adolesc Health; 2023 Mar; 7(3):214-222. PubMed ID: 36682367
[TBL] [Abstract][Full Text] [Related]
7. The status of paediatric medicines initiatives around the world--What has happened and what has not?
Hoppu K; Anabwani G; Garcia-Bournissen F; Gazarian M; Kearns GL; Nakamura H; Peterson RG; Sri Ranganathan S; de Wildt SN
Eur J Clin Pharmacol; 2012 Jan; 68(1):1-10. PubMed ID: 21732178
[TBL] [Abstract][Full Text] [Related]
8. EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making.
Plueschke K; McGettigan P; Pacurariu A; Kurz X; Cave A
BMJ Open; 2018 Jun; 8(6):e021864. PubMed ID: 29903798
[TBL] [Abstract][Full Text] [Related]
9. Paediatric Medicines in Europe: The Paediatric Regulation-Is It Time for Reform?
Toma M; Felisi M; Bonifazi D; Bonifazi F; Giannuzzi V; Reggiardo G; de Wildt S; Ceci A;
Front Med (Lausanne); 2021; 8():593281. PubMed ID: 33604345
[No Abstract] [Full Text] [Related]
10. Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation.
Tomasi PA; Egger GF; Pallidis C; Saint-Raymond A
Paediatr Drugs; 2017 Dec; 19(6):505-513. PubMed ID: 28900869
[TBL] [Abstract][Full Text] [Related]
11. UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational study.
Bragginton EC; Piddock LJ
Lancet Infect Dis; 2014 Sep; 14(9):857-68. PubMed ID: 25065509
[TBL] [Abstract][Full Text] [Related]
12. More medicines for children: impact of the EU paediatric regulation.
Nordenmalm S; Tomasi P; Pallidis C
Arch Dis Child; 2018 Jun; 103(6):557-564. PubMed ID: 29490933
[TBL] [Abstract][Full Text] [Related]
13. The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children.
Turner MA; Hildebrand H; Fernandes RM; de Wildt SN; Mahler F; Hankard R; Leary R; Bonifazi F; Nobels P; Cheng K; Attar S; Rossi P; Rocchi F; Claverol J; Nafria B; Giaquinto C
Pharmaceut Med; 2021 Mar; 35(2):71-79. PubMed ID: 33539007
[TBL] [Abstract][Full Text] [Related]
14. Usage of unpublished paediatric data.
Saint-Raymond A; Pelle B; Zaccaria C; Sennwitz M; Branch S
Arch Dis Child; 2016 Jan; 101(1):81-4. PubMed ID: 26543071
[TBL] [Abstract][Full Text] [Related]
15. European Union investment and countries' involvement in mental health research between 2007 and 2013.
Hazo JB; Gervaix J; Gandré C; Brunn M; Leboyer M; Chevreul K
Acta Psychiatr Scand; 2016 Aug; 134(2):138-49. PubMed ID: 27145870
[TBL] [Abstract][Full Text] [Related]
16. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
17. [Establishing ophthalmology in the research framework programs of the European Union].
Scholl HP; Wheeler-Schilling TH; Zrenner E; Holz FG
Ophthalmologe; 2006 Feb; 103(2):91-9. PubMed ID: 16437232
[TBL] [Abstract][Full Text] [Related]
18. Public-private partnership models in France and in Europe.
Demotes-Mainard J; Canet E; Segard L
Therapie; 2006; 61(4):325-34, 313-23. PubMed ID: 17124948
[TBL] [Abstract][Full Text] [Related]
19. How to Apply for and Secure EU Funding for Collaborative IBD Research Projects.
Satsangi J; Kitten O; Chavez M; Kalla R; Prel N; Meuwis MA; Scott S; Bonetti I; Ventham NT; Louis E
J Crohns Colitis; 2016 Mar; 10(3):363-70. PubMed ID: 26744440
[TBL] [Abstract][Full Text] [Related]
20. Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases.
Stefanska AM; Distlerová D; Musaus J; Olski TM; Dunder K; Salmonson T; Mentzer D; Müller-Berghaus J; Hemmings R; Veselý R
Arch Dis Child; 2017 Oct; 102(10):952-957. PubMed ID: 28554892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
